CKPT - Checkpoint Therapeutics, Inc. Quarterly EPS earnings growth

Brandmark of Checkpoint Therapeutics, Inc. (CKPT)

Can a dumping strategy utilizing affordable immunotherapy analogs deliver a financial breakthrough for Checkpoint Therapeutics (CKPT)? The quarterly EPS growth trajectory provides the answer, while the 44.40 metric indicates the profit status. The development of new treatment methods relies on partnerships with research centers. Business stability is supported by the neutral geopolitical status of biomedicine, which shields the company from external sanctions.

checkpointtx.com (CKPT) - Year-over-year net earnings per share growth for the last 12 months from 07/04/2022 to 06/07/2025

Analytical breakdowns for Checkpoint Therapeutics

- market value and analyst target forecast:
Price Chart Checkpoint Therapeutics, Inc.|CKPT - Fair Value Consensus
- market capitalization statistics:
Market Capitalization Checkpoint Therapeutics, Inc|CKPT - Total Enterprise Value
- balance sheet net asset value indicators:
Book Value per Share Checkpoint Therapeutics|CKPT - Company Net Assets|Market Capitalization to Book Value Ratio checkpointtx.com|CKPT - Aggregate Asset Value
- company liabilities and liquidity data:
Total Debt to Capital Checkpoint Therapeutics|CKPT - Long-Term Liabilities to Capital|Short-Term Debt to Capital Checkpoint Therapeutics|CKPT - Company Total Debt|Debt to Book Capitalization Ratio Checkpoint Therapeutics, Inc|CKPT - Company Long-Term Debts|Company Short-Term Debt Checkpoint Therapeutics|Quick Liquidity checkpointtx.com
- earnings and valuation multiples indicators:
CKPT - Company Net Income|Projected Future Earnings Checkpoint Therapeutics|CKPT - Business Payback Period|Future Price to Earnings Checkpoint Therapeutics, Inc|CKPT - Growth-Adjusted P/E Ratio|Enterprise Value to EBITDA Ratio Checkpoint Therapeutics, Inc|CKPT - Company profit before taxes, interest and amortization|Net earnings per share for the last 12 months Checkpoint Therapeutics|CKPT - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months checkpointtx.com|CKPT - Net earnings per one share growth for the current year|Earnings growth forecast for next year Checkpoint Therapeutics
Basic company analysis:Checkpoint Therapeutics
Flagship merchandise of Checkpoint Therapeutics Inc

Quarterly EPS growth measures the dynamics of net profit per share, allowing for the identification of asset overvaluation prior to the publication of financial statements through the analysis of market demand. By tracking the quarterly change in earnings per share, an investor can assess how effectively Checkpoint Therapeutics (CKPT) converts its expenditures on complex medical logistics and the preservation of immunotherapeutic drugs within supply chains into financial results.

Competitor analysis

BeiGene (ONC) - Year-over-year earnings per share growth for the last twelve months|Halozyme Therapeutics, Inc. - Year-over-year earnings per one share growth for the last 12 months|RVMD (RevMed) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Ascentage Pharma Corp AAPG|Quarterly EPS earnings growth CGON|Year-over-year net earnings per share growth for the last 12 months urogen.com URGN|Quarterly EPS earnings growth BCAX (Bicara Therapeutics)|Year-over-year earnings per one share growth for the last 12 months PSNL|Erasca Corp - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Delcath Corp|YMAB: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months aurabiosciences.com|Year-over-year earnings per share growth for the last twelve months Candel Therapeutics Inc.|Quarterly EPS earnings growth Accuray Inc|Year-over-year earnings per share growth for the last twelve months SELLAS Life Sciences (SLS)|ACTU: Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Citius Oncology, Inc. CTOR|TuHURA Biosciences Inc. (HURA) - Earnings per share growth in annualized terms for the last twelve months|Protara Therapeutics, Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Fate Therapeutics Inc FATE|aadibio.com (WHWK) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months TCRX|Year-over-year net earnings per share growth for the last 12 months CSBR|XBIT (XBiotech USA) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CVM (CEL-SCI Corporation)|OSTX (OS Therapies Inc.) - Year-over-year earnings per one share growth for the last 12 months|Radiopharm Theranostics - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months ARTV (Artiva Biotherapeutics Inc.)|Adlai Nortye Limited - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months VERU (verupharma.com)|TPST: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Xilio Therapeutics (XLO)|Year-over-year earnings per share growth for the last twelve months Renovaro Biosciences|MURA: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth KAPA|Quarterly EPS earnings growth onkuretherapeutics.com (OKUR)|Year-over-year earnings per share growth for the last twelve months CytoMed Therapeutics Limited GDTC|CRIS (Curis Inc.) - Year-over-year net earnings per share trend for the last twelve months|Apollomics Corp - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Tharimmune Corporation|ADVB (advanbiomed.com) - Year-over-year net earnings per share growth for the last 12 months|genprex.com (GNPX) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months CLDI|SBFM (sunshinebiopharma.com) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth XBIO|Year-over-year net earnings per share change for the last twelve months Salarius Pharma|Quarterly EPS earnings growth PPBT (Purple Biotech)|AONC - Year-over-year net earnings per share growth for the last 12 months|BGNE - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Elevation Oncology Inc. ELEV|ICAD: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Ikena Oncology|Year-over-year earnings per share growth for the last twelve months Notable Labs, Ltd.|Quarterly EPS earnings growth Viracta|Year-over-year earnings per share growth for the last twelve months MorphoSys (MOR)|NAYA: Year-over-year net earnings per share trend for the last twelve months|Ascentage Pharma Group Ltd - Year-over-year net earnings per share growth for the last 12 months